Genenta Science S.p.A. (SAEN) stock
SAENNasdaqBiological Products, (No Diagnostic Substances)Also trades as GNTA
$0.60−0.05 (-7.66%)
Close on Nov 16, 2026Market cap $14.06MP/E –Yield –
Genenta Science S.p.A. total assets
Total assets on the balance sheet at the end of each period.
Genenta Science S.p.A.'s total assets was €31.89M at Dec 31, 2025. For fiscal 2025 it was €31.89M, up 115.1% from the year before. The highest annual figure on record is €40.03M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €31.89M | +115.1% |
| FY2024 | Dec 31, 2024 | €14.82M | -33.7% |
| FY2023 | Dec 31, 2023 | €22.35M | -33.2% |
| FY2022 | Dec 31, 2022 | €33.44M | -16.5% |
| FY2021 | Dec 31, 2021 | €40.03M | +128.7% |
| FY2020 | Dec 31, 2020 | €17.50M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | €31.89M | +42.7% |
| Q2 FY2025 | Jun 30, 2025 | €21.55M | -19.4% |
| Q4 FY2024 | Dec 31, 2024 | €14.82M | -55.7% |
| Q2 FY2024 | Jun 30, 2024 | €19.02M | -50.3% |
| Q4 FY2023 | Dec 31, 2023 | €22.35M | -44.2% |
| Q2 FY2023 | Jun 30, 2023 | €26.73M | +52.7% |
| Q4 FY2022 | Dec 31, 2022 | €33.44M | – |
| Q2 FY2022 | Jun 30, 2022 | €38.28M | – |
| Q4 FY2021 | Dec 31, 2021 | €40.03M | – |
| Q4 FY2020 | Dec 31, 2020 | €17.50M | – |
See a number that looks wrong?